Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: A meta-analysis; [Keine Assoziation zwischen PON1-Q192R- und -L55M-Polymorphismen und Langlebigkeit beim Menschen: Eine Metaanalyse]

被引:0
|
作者
Wei G.-Z. [1 ]
Zhu M.-Y. [1 ]
Wang F. [1 ]
Zhao Y.-G. [1 ]
Li S.-S. [1 ]
Liu T.-Y. [1 ]
Luo Y. [1 ]
Tang W.-R. [1 ]
机构
[1] Laboratory of Molecular Genetics of Aging and Tumor, Medical Faculty, Kunming University of Science and Technology, Chenggong Campus, 727 South Jingming Road, Kunming, 650500, Yunnan
关键词
Aged; 80 and over; Aging genetics; Alleles; Genotype; Humans;
D O I
10.1007/s00391-015-0892-1
中图分类号
学科分类号
摘要
Background: Genetic mutations in the paraoxonase 1 (PON1) encoding gene have been considered to affect mortality and of these the functional promoter region polymorphisms Q192R and L55M are among the most widely studied. Objective: The aim of this study was to determine whether the Q192R and L55M polymorphisms of PON1 can increase susceptibility to longevity. A meta-analysis was performed to obtain a comprehensive estimation of the association between Q192R and L55M and longevity in long-lived individuals (LLIs) aged 80 years or more. Material and methods: A search was carried out in the PubMed database (from January 2001 to May 2014) to obtain data on the role of PON1 polymorphisms in longevity and a pooled odds ratio (OR) with a 95 % confidence interval (CI) was used to assess the associations. Results: The meta-analysis was based on 9 studies of PON1 Q192R and 5 studies of PON1 L55M that covered a total of 5086 LLIs and 4494 controls. Overall, significantly increased risks were not observed for either Q192R or L55M. The results of the statistical calculations were as follows: R vs. Q (additive model): OR = 1.080, 95 % CI = 0.989–1.179, p = 0.088 and RR + RQ vs. QQ (dominant model): OR = 1.099, 95 % CI = 0.975–1.240, p = 0.124; M vs. L (additive model): OR = 0.946, 95 % CI = 0.862–1.039, p = 0.245 and MM + ML vs. LL (dominant model): OR = 0.951, 95 % CI = 0.836–1.081, p = 0.442 for Q192R and L55M, respectively. The results did not change with an age cut-off among the LLIs of ≥ 93 years. Conclusion: No evidence that the Q192R and L55M polymorphisms of PON1 impacted on the probability of reaching extreme ages was found although this cannot be completely ruled out; however, the possibility of population-specific effects due to the influence of and interaction between different genes or environmental factors could not be ruled out. © 2015, Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:24 / 31
页数:7
相关论文
共 50 条
  • [21] Relationship between the paraoxonase 1 (PON1) M55L and Q192R polymorphisms and lymphohaematopoietic cancers in a Greek agricultural population
    Kokouva, Maria
    Koureas, Michalis
    Dardiotis, Efthimios
    Almpanidou, Pavlina
    Kalogeraki, Alexandra
    Kyriakou, Despoina
    Hadjigeorgiou, Georgios M.
    Hadjichristodoulou, Christos
    TOXICOLOGY, 2013, 307 : 12 - 16
  • [22] PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia: Clinical study of possible associations
    Chen, H.
    Ding, S.
    Zhou, M.
    Wu, X.
    Liu, X.
    Liu, J.
    Wu, Y.
    Liu, D.
    HERZ, 2018, 43 (07) : 642 - 648
  • [23] Genetic Polymorphisms of Paraoxonase 1 (PON1) Gene: Association Between L55M or Q192R with Breast Cancer Risk and Clinico-Pathological Parameters
    Naidu, Rakesh
    Har, Yip Cheng
    Taib, Nur Aishah Mohd
    PATHOLOGY & ONCOLOGY RESEARCH, 2010, 16 (04) : 533 - 540
  • [24] The paraoxonase L55M and Q192R gene polymorphisms and myocardial infarction in a Tunisian population
    Kallel, Amani
    Sediri, Yousra
    Sbai, Mohamed Hedi
    Mourali, Mohamed Sami
    Feki, Moncef
    Elasmi, Monia
    Taieb, Samah Haj
    Sanhaji, Haifa
    Souheil, Omar
    Mechmeche, Rachid
    Jemaa, Riadh
    Kaabachi, Naziha
    CLINICAL BIOCHEMISTRY, 2010, 43 (18) : 1461 - 1463
  • [25] Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients
    Sardo, MA
    Campo, S
    Bonaiuto, M
    Bonaiuto, A
    Saitta, C
    Trimarchi, G
    Castaldo, M
    Bitto, A
    Cinquegrani, M
    Saitta, A
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (05) : 777 - 784
  • [26] Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: A meta-analysis
    Pi, Yan
    Zhang, Lili
    Chang, Kai
    Li, Binghu
    Guo, Lu
    Fang, Chuanqin
    Gao, Changyue
    Wang, Jingzhou
    Xiang, Jing
    Li, Jingcheng
    NEUROSCIENCE LETTERS, 2012, 523 (02) : 174 - 179
  • [27] PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemiaClinical study of possible associationsPON1 L55M-/Q192R-Genpolymorphismen und KHK-Risiko bei HyperlipidämieKlinische Untersuchung möglicher Beziehungen
    H. Chen
    S. Ding
    M. Zhou
    X. Wu
    X. Liu
    J. Liu
    Y. Wu
    D. Liu
    Herz, 2018, 43 : 642 - 648
  • [28] Are PON1 Q/R 192 and M/L 55 polymorphisms risk factors for diabetes complications in Turkish population?
    Altuner, Durdu
    Suzen, Sinan H.
    Ates, Ilker
    Koc, Gonul V.
    Aral, Yalcin
    Karakaya, Asuman
    CLINICAL BIOCHEMISTRY, 2011, 44 (5-6) : 372 - 376
  • [29] PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population
    Arca, M
    Ombres, D
    Montali, A
    Campagna, F
    Mangieri, E
    Tanzilli, G
    Campa, PP
    Ricci, G
    Verna, R
    Pannitteri, G
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (01) : 9 - 15
  • [30] DNA damage in a Chilean population exposed to pesticides and its association with PON1 (Q192R and L55M) susceptibility biomarker
    Zuniga-Venegas, Liliana
    Pancetti, Floria C.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2022, 63 (04) : 215 - 226